• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

修订后的子宫内膜癌国际妇产科联盟(FIGO)分期系统。

Revised FIGO staging system for endometrial cancer.

作者信息

Lewin Sharyn N

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA.

出版信息

Clin Obstet Gynecol. 2011 Jun;54(2):215-8. doi: 10.1097/GRF.0b013e3182185baa.

DOI:10.1097/GRF.0b013e3182185baa
PMID:21508690
Abstract

In 1988 the International Federation of Gynecologists and Obstetricians (FIGO) developed a surgical staging system for endometrial cancer. The FIGO staging system was recently revised in 2009 to reflect our growing understanding of the natural history of endometrial cancer. In this review, we describe the revised 2009 FIGO staging system for tumors of the uterine corpus and examine the effect of the new changes in the staging criteria.

摘要

1988年,国际妇产科联合会(FIGO)制定了子宫内膜癌的手术分期系统。FIGO分期系统最近在2009年进行了修订,以反映我们对子宫内膜癌自然史的不断深入理解。在本综述中,我们描述了2009年修订的子宫体肿瘤FIGO分期系统,并探讨分期标准新变化的影响。

相似文献

1
Revised FIGO staging system for endometrial cancer.修订后的子宫内膜癌国际妇产科联盟(FIGO)分期系统。
Clin Obstet Gynecol. 2011 Jun;54(2):215-8. doi: 10.1097/GRF.0b013e3182185baa.
2
Surgicopathologic staging of endometrial adenocarcinoma.子宫内膜腺癌的外科病理分期
Curr Opin Obstet Gynecol. 1994 Feb;6(1):92-7.
3
Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes.子宫内膜癌——重新审视盆腔及腹主动脉旁淋巴结的重要性
Gynecol Oncol. 2007 Jan;104(1):222-31. doi: 10.1016/j.ygyno.2006.10.013. Epub 2006 Nov 28.
4
[Clinical significance of the revised international federation of gynecology and obstetrics staging system 2009].[2009年修订的国际妇产科联盟分期系统的临床意义]
Zhonghua Fu Chan Ke Za Zhi. 2010 Oct;45(10):721-4.
5
Comparison of FIGO 1989 and 2009 recommendations on staging of endometrial carcinoma: pathologic analysis and cervical status in 123 consecutive cases.FIGO 1989 年和 2009 年关于子宫内膜癌分期推荐的比较:123 例连续病例的病理分析和宫颈状态。
Int J Gynecol Pathol. 2011 Jul;30(4):328-34. doi: 10.1097/PGP.0b013e3182069c30.
6
A validation study of the new revised FIGO staging system to estimate prognosis for patients with stage IIIC endometrial cancer.新修订的FIGO 分期系统对估计 IIIC 期子宫内膜癌患者预后的验证研究。
Gynecol Oncol. 2011 Apr;121(1):126-30. doi: 10.1016/j.ygyno.2010.12.001. Epub 2010 Dec 30.
7
Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.子宫内膜癌组织学分级系统的预后意义及观察者间变异性
Cancer. 2004 Feb 15;100(4):764-72. doi: 10.1002/cncr.20040.
8
Evaluation of DNA ploidy in endometrial cancer.子宫内膜癌中DNA倍体的评估。
Gynecol Oncol. 1993 Jul;50(1):25-9. doi: 10.1006/gyno.1993.1158.
9
[Endometrial cancer. Clinico-surgical classification and treatment results (analysis of 134 patients)].[子宫内膜癌。临床手术分类及治疗结果(134例患者分析)]
Ginecol Obstet Mex. 1998 Sep;66:381-8.
10
[The comparison of clinical and surgical-pathological staging for endometrial carcinoma].[子宫内膜癌临床分期与手术病理分期的比较]
Zhonghua Fu Chan Ke Za Zhi. 1997 Oct;32(10):597-600.

引用本文的文献

1
Multimodal MRI Image Fusion for Early Automatic Staging of Endometrial Cancer.用于子宫内膜癌早期自动分期的多模态磁共振成像图像融合
Sensors (Basel). 2025 May 6;25(9):2932. doi: 10.3390/s25092932.
2
Peritoneal washings analysis in endometrial cancer: Comparison of somatic mutation detection with panel sequencing and traditional cytology.子宫内膜癌的腹腔冲洗液分析:体细胞突变检测在Panel测序与传统细胞学之间的比较
Gynecol Oncol. 2025 Jun;197:155-162. doi: 10.1016/j.ygyno.2025.05.002. Epub 2025 May 9.
3
Model Predicting the Risk of Endometrial Hyperplasia Developing into Endometrial Cancer.
预测子宫内膜增生发展为子宫内膜癌风险的模型
J Inflamm Res. 2024 Sep 7;17:6159-6171. doi: 10.2147/JIR.S471620. eCollection 2024.
4
Preclinical evaluation of avutometinib and defactinib in high-grade endometrioid endometrial cancer.在高级别子宫内膜样子宫内膜癌中评估 avutomib 和 defactinib 的临床前评价。
Cancer Med. 2024 Sep;13(17):e70210. doi: 10.1002/cam4.70210.
5
Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis.整合蛋白质组学与可解释人工智能:子宫内膜癌诊断和预后蛋白质生物标志物的综合分析
Front Mol Biosci. 2024 Jun 3;11:1389325. doi: 10.3389/fmolb.2024.1389325. eCollection 2024.
6
The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.分析临床 I 期子宫内膜样癌患者手术病理分期升级的术前或术中因素:一项回顾性临床研究。
Medicine (Baltimore). 2024 Mar 15;103(11):e37465. doi: 10.1097/MD.0000000000037465.
7
Impact of artificial intelligence on the diagnosis, treatment and prognosis of endometrial cancer.人工智能对子宫内膜癌诊断、治疗及预后的影响
Ann Med Surg (Lond). 2024 Jan 17;86(3):1531-1539. doi: 10.1097/MS9.0000000000001733. eCollection 2024 Mar.
8
The Potential of Liquid Biopsy in Detection of Endometrial Cancer Biomarkers: A Pilot Study.液体活检在检测子宫内膜癌生物标志物中的潜力:一项初步研究。
Int J Mol Sci. 2023 Apr 25;24(9):7811. doi: 10.3390/ijms24097811.
9
Prognostic factors in endometrial cancer patients with bone metastasis.子宫内膜癌骨转移患者的预后因素。
Jt Dis Relat Surg. 2023;34(1):207-214. doi: 10.52312/jdrs.2023.792. Epub 2023 Jan 6.
10
Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?Ⅰ 期子宫内膜透明细胞癌和浆液性癌:何种辅助治疗为优?
Curr Oncol. 2023 Jan 14;30(1):1174-1185. doi: 10.3390/curroncol30010090.